Literature DB >> 2140574

Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.

B H Paw1, S M Moskowitz, N Uhrhammer, N Wright, M M Kaback, E F Neufeld.   

Abstract

Juvenile GM2 gangliosidosis is a rare neurodegenerative disorder closely related to Tay-Sachs disease but of later onset and more protracted course. The biochemical defect lies in the alpha-subunit of the lysosomal enzyme beta-hexosaminidase. Cultured fibroblasts derived from patient A synthesized an alpha-subunit which could acquire mannose 6-phosphate and be secreted, but which failed to associate with the beta-subunit to form the enzymatically active heterodimer. By contrast, fibroblasts from patient B synthesized an alpha-subunit that was retained in the endoplasmic reticulum. To identify the molecular basis of the disorder, RNA from fibroblasts of these two patients was reverse-transcribed, and the cDNA encoding the alpha-subunit of beta-hexosaminidase was amplified by the polymerase chain reaction (PCR) in four overlapping fragments. The PCR fragments were subcloned and shown by sequence analysis to contain a G to A transition corresponding to substitution of histidine for arginine at position 504 in the case of patient A and at position 499 in the case of patient B. The mutations were confirmed by hybridization of allele-specific oligonucleotides to PCR-amplified fragments of DNA corresponding to exon 13 of the alpha-subunit gene. The Arg504----His mutation was found on both alleles of patient A as well as of another unrelated patient; the homozygosity of this mutant allele is attributable to consanguinity in the two families. The Arg499----His mutation was found in patient B in compound heterozygosity with a common infantile Tay-Sachs allele. There is additional heterogeneity in juvenile GM2 gangliosidosis, as neither mutation was found in the DNA of a fourth patient. The Arg----His mutations at positions 499 and 504 are located at CpG dinucleotides, which are known to be mutagenic "hot spots."

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140574

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites.

Authors:  T M Bradford; M J Gething; R Davey; J J Hopwood; D A Brooks
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

2.  Structural basis of the GM2 gangliosidosis B variant.

Authors:  Fumiko Matsuzawa; Sei-ichi Aikawa; Hitoshi Sakuraba; Hoang Thi Ngoc Lan; Akemi Tanaka; Kousaku Ohno; Yuko Sugimoto; Haruaki Ninomiya; Hirofumi Doi
Journal:  J Hum Genet       Date:  2003-10-24       Impact factor: 3.172

3.  Cloning and sequence analysis of a cDNA encoding the alpha-subunit of mouse beta-N-acetylhexosaminidase and comparison with the human enzyme.

Authors:  T Beccari; J Hoade; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

4.  Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.

Authors:  M Kaur; I C Verma
Journal:  Indian J Pediatr       Date:  1995 Jul-Aug       Impact factor: 1.967

5.  Teleost growth factor independence (gfi) genes differentially regulate successive waves of hematopoiesis.

Authors:  Jeffrey D Cooney; Gordon J Hildick-Smith; Ebrahim Shafizadeh; Paul F McBride; Kelli J Carroll; Heidi Anderson; George C Shaw; Owen J Tamplin; Diana S Branco; Arthur J Dalton; Dhvanit I Shah; Clara Wong; Patrick G Gallagher; Leonard I Zon; Trista E North; Barry H Paw
Journal:  Dev Biol       Date:  2012-08-29       Impact factor: 3.582

Review 6.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

7.  Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4.

Authors:  Gordon J Hildick-Smith; Jeffrey D Cooney; Caterina Garone; Laura S Kremer; Tobias B Haack; Jonathan N Thon; Non Miyata; Daniel S Lieber; Sarah E Calvo; H Orhan Akman; Yvette Y Yien; Nicholas C Huston; Diana S Branco; Dhvanit I Shah; Matthew L Freedman; Carla M Koehler; Joseph E Italiano; Andreas Merkenschlager; Skadi Beblo; Tim M Strom; Thomas Meitinger; Peter Freisinger; M Alice Donati; Holger Prokisch; Vamsi K Mootha; Salvatore DiMauro; Barry H Paw
Journal:  Am J Hum Genet       Date:  2013-10-10       Impact factor: 11.025

Review 8.  Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.

Authors:  Elena Chiricozzi; Natalia Niemir; Massimo Aureli; Alessandro Magini; Nicoletta Loberto; Alessandro Prinetti; Rosaria Bassi; Alice Polchi; Carla Emiliani; Catherine Caillaud; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-12-20       Impact factor: 5.590

9.  Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.

Authors:  Akemi Tanaka; Lan Thi Ngcok Hoang; Yasuaki Nishi; Satoshi Maniwa; Makio Oka; Tsunekazu Yamano
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

10.  Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.

Authors:  E H Mules; S Hayflick; C S Miller; L W Reynolds; G H Thomas
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.